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Abstract 
 
The use of multivalent carbohydrate compounds to block cell-surface lectin receptors is a 
promising strategy for inhibiting the entry of pathogens into cells and could lead to the 
discovery of novel antiviral agents. One of the main problems with this approach, however, is 
the difficulty in making compounds with adequate size and multivalency to mimic natural 
systems such as viruses. Hexakis-adducts of [60]fullerene are a useful building block in this 
regard because they maintain a globular shape while allowing control over size and 
multivalency. Here we report water-soluble tridecafullerenes decorated with 120 peripheral 
carbohydrate subunits, so-called 'superballs', that can be efficiently synthesized from hexakis-
adducts of [60]fullerene in one step by using copper-catalyzed azide–alkyne cycloaddition 
(CuAAC) click-chemistry. Infection assays show that these 'superballs' are potent inhibitors of 
cell infection by an artificial Ebola virus with IC50s in the sub-nanomolar range.  
 
  
Multivalency is a general and efficient tool used by nature for achieving strong interactions in a 
reversible manner. At the molecular level, multivalent interactions have the advantage of 
enhancing drastically the binding between molecules when compared with monovalent 
binding.1 
A remarkable example from nature where multivalency plays a significant role is the 
interaction between viruses and bacteria with their respective host cells. In particular, DC-SIGN 
(dendritic cell-speciﬁc intercellular adhesion molecule-3-grabbing non-integrin) receptor is one 
of the most important pathogen recognition receptors. This lectin efficiently recognizes in a 
multivalent manner saccharides containing mannoses and fucoses from glycoproteins.2 In this 
regard, it is well established that protein−carbohydrate interactions are a key issue in a variety 
of biological processes, but since the aﬃnity of simple glycans for their respective receptors is 
often weak, multivalent interactions typically occur. An important open challenge of research 
nowadays is the better understanding and practical use of multivalency. Actually, in a broader 
sense, glycobiology is currently a field of research where chemically inspired approaches and 
strategies are producing significant advances.3 
It is well-known, however, that some viruses are able to escape from processing by the 
immune defense by using DC-SIGN as an entry point to infect the cell. Therefore, inhibiting the 
entry of pathogens by blocking this receptor at the early stages of infection represents a 
valuable strategy for the design of new antiviral agents. In order to address this challenge, a 
variety of different multivalent scaffold architectures have been synthesized, all of them 
endowed with multiple carbohydrates.4 Design of these glyco-conjugates typically requires a 
multivalent central scaffold or core covalently connected to the carbohydrate epitopes 
decorating the periphery. Thus, glyco-clusters in which the carbohydrate units are directly 
connected to the core, glyco-dendrimers connected through a dendritic structure, and glyco-
polymers involving a polymeric backbone have been intensively investigated in recent years.5-9 
Fullerenes have also been employed as a biocompatible scaffold for the multivalent 
presentation of ligands, given the possibility of multiple functionalization on their convex 
surface. In particular, hexakis-adducts of [60]fullerene with a Th-symmetrical octahedral 
addition pattern have a unique three-dimensional structure which allows the introduction of 
six one-type or mixed-type addends.10,11 Such derivatives can be obtained in one synthetic step 
by the addition of malonates to C60, but this approach has been limited by the low yields that 
result when larger malonates are used because the reaction is very sensitive to steric effects.12 
We have recently developed a procedure based on a click-chemistry approach which provides 
hexakis-adducts with twelve alkyne or azide terminal groups in high yields from simple 
malonates.13,14 These hexakis-adducts can be easily and efficiently functionalized by using the 
copper-catalyzed azide–alkyne cycloaddition (CuAAC) reaction allowing the introduction of 
twelve functional groups simultaneously in a regioselective and efficient way. Since these 
hexakis-adducts show an octahedral arrangement of equally separated addends located on the 
[60]fullerene periphery in a globular topology, they constitute a very attractive platform for 
the study of multivalent interactions with lectins, with important advantages such as the 
better biocompatibility of the carbon central core, the globular geometry of the functional 
groups and the ease and versatile chemical functionalization. 
We have recently reported the syntheses of [60]fullerene hexakis-adducts endowed with 
different carbohydrate units in the periphery. Depending upon the starting sugar derivatives 
employed (monomer, dimer or trimer) 12, 24 and up to 36 monosaccharides have been 
introduced on the periphery of the fullerene central core in a straightforward manner.14-17  
Some of the aforementioned glycofullerenes have shown interesting bio-medical 
applications.18 A significant multivalent effect has been observed in the inhibition profile of a 
[60]fullerene hexakis-adduct endowed with 12 iminosugar units towards different 
glycosidases.16 On the other hand, fullerene hexakis-adducts bearing 12 mannoses on the 
periphery behave as inhibitors of FimH, a bacterial adhesin.19 Furthermore, studies carried out 
on hexakis-adducts of [60]fullerene endowed with 12, 24 and 36 mannoses have shown a 
multivalent effect in the interaction with concanavalin A,15 and act as efficient inhibitors of cell 
infection by Ebola pseudotyped viral particles.20 These preliminary studies reveal that 
fullerenes are adequate platforms for the multivalent presentation of carbohydrates, thus 
paving the way to the covalent linkage of a wide variety of different bio-active molecules in a 
multivalent manner and a singular and less-explored globular topology. 
In this work, we have synthesized molecules with a globular topology formed by an hexakis-
adduct of hexakis adducts of [60]fullerene, carrying out the fastest dendrimeric growth 
reported up to now, with the introduction of 120 sugar units in one synthetic step by using the 
highly efficient CuAAC click-chemistry methodology. The synthesis of hexakis-adducts of 
hexakis-adducts of [60]fullerene with an octahedral addition pattern has previously been 
reported. This previous example used macrocyclic bis-malonates and enabled the synthesis of 
heptafullerenes with tunable properties.21-23 In contrast, our click-chemistry approach yields 
tridecafullerenes in which the central [60]fullerene is covalently connected to twelve 
[60]fullerenes, each of them endowed, in turn, with ten monosaccharides. To confirm the 
proposed structures, we have carried out a thorough structural study involving a variety of 
techniques (Infrared, 1H NMR and 13C NMR spectroscopy; dynamic light scattering (DLS), 
transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS)). 
Biological studies reveal that the new giant glycofullerenes exhibit a very strong inhibition of 
cell infection by Ebola pseudotyped viral particles with IC50 values in the sub-nanomolar range. 
Synthesis 
The synthesis of the glycofullerene superballs has been carried out as depicted in Figures 1-3. 
Although these molecules (17a-c) may appear difficult to obtain at a first glance, mainly due to 
their size and molecular complexity, their synthesis is straightforward and, most importantly, 
easily reproducible affording the final compounds in good overall yields. Furthermore, as 
discussed below, purification of the samples — including the required removal of copper for 
further biological studies — are carried out easily because after column filtration these 
compounds (17a,b) are precipitated in the reaction medium and pure samples showing highly 
reproducible biological assays are obtained. 
With the aim of studying the effect of the size and/or steric congestion of these superballs on 
the biological properties, two different and complementary synthetic strategies have been 
simultaneously developed to obtain final products with different spacers inbetween the 
central fullerene core and the peripheral carbohydrate-substituted fullerene appendages. In 
both cases, the synthesis relies on the grafting of clickable A10B macromonomers onto a 
compact C60 hexa-adduct scaffold bearing twelve terminal alkyne units. The preparation of 
macromonomer 9 is depicted in Figure 1. Esterification of alcohol 1 with ethylmalonyl chloride 
followed by reaction of the resulting malonate (2) with C60 under Bingel conditions gave 
methanofullerene 3. Subsequent treatment of 3 with an excess of malonate 4, CBr4, and DBU 
in o-dichorobenzene (ODCB) gave building block 5 to which mannose derivative 6 was clicked. 
Importantly, the TMS-protected alkyne unit is not reactive under these conditions and 
intermediate 7 was thus obtained in a good yield. Finally, compound 7 was desilylated in situ 
with tetrabutylammonium fluoride (TBAF) to generate the corresponding terminal alkyne and 
reaction with a large excess of diazide 8 provided the desired macromonomer 9 in 87% yield.  
The synthesis of macromonomers 15a-b starts from monoadduct 10 resulting from the Bingel 
nucleophilic cyclopropanation of C60 with 6-bromohexyl ethyl malonate (Figure 2).
24 To obtain 
the [5:1]-hexaadduct 12, a tenfold excess amount of di(pent-4-yn-1-yl) malonate and a 50-
fold excess of carbon tetrabromide were added in the presence of DBU as the base. Flash 
chromatography purification provided hexaadduct 12 as a red solid. Different carbohydrate 
azides (mannose, galactose) were then linked to C60 by the CuAAC reaction, employing 
CuBr·S(CH3)2 as the catalyst and sodium ascorbate as the reducing agent in the presence of a 
piece of metallic Cu, to yield derivatives 14a-b. The nucleophilic substitution of bromine by 
azide was carried out with an excess of sodium azide under microwave heating, thus giving 
versatile building blocks 15a-b.  
The azide-containing macromonomers 9 and 14a-b were then clicked to symmetric alkyne 
derivative 1614 under CuAAC conditions. Superballs 17a-c substituted with up to 120 
monosaccharide units were thus obtained with yields over 70% (Figure 3). Derivatives 17a-b 
were obtained in only three synthetic steps from easily accessible reactives and avoiding the 
use of protecting groups.  
Although the three tridecafullerenes 17a-c contain the same number of monosaccharides, 
compound 17c has a larger spacer between the central fullerene moiety and the peripheral 
carbohydrate functionalized fullerenes. This longer spacer affects the flexibility and the size of 
the compound and can favour the accessibility and availability of the carbohydrate ligands to 
interact with the receptor, which could have an important influence on the biological activity.20 
It is important to note, however, that the aforementioned synthetic approaches enables 
fullerene derivatives to be synthesized from malonates endowed with alkyl chains of variable 
length through a Bingel cyclopropanation followed by a subsequent CuAAC reaction. This 
synthetic strategy affords hexakis-adducts with long chains connecting the fullerenes and 
carbohydrates since their direct preparation from suitably functionalized malonates bearing 
long chains typically occur with low yields.10 
Characterization of these superballs was carried out by standard spectroscopic techniques. 
Thus, FTIR spectra do not show the presence of either azide groups (typical signal observed at 
2097 cm-1) or alkynes ( 2117 cm-1) (See the Supplementary Information). The molecular ion 
peak of these compounds could not be detected but it should be noted that the transfer of 
such high molecular weight glycoclusters into the gas phase during MALDI-TOF MS analysis is 
very difficult. Moreover, both the sugars and the fullerene hexaadduct moieties give rise to a 
high level of fragmentation.25 The unambiguous structural characterization of 17a-c was, 
however, greatly facilitated by their high symmetry. Indeed, 13C NMR spectroscopy was 
particularly helpful for the characterization of hexakis-adducts of [60]fullerene, as only two 
signals are usually observed for the sp2 carbons of C60, providing evidence for the octahedral 
symmetry of the fullerene core. As a typical example, the 13C NMR spectrum of compound 17a 
is depicted in Figure 4. In this case, only two sp2 carbons are observed in the spectra (δ  145.4 
and 141.6 ppm), where we can also distinguish the two different kinds of triazole rings present 
in the compound (at δ  146.9 and 123.3 ppm for the carbons of the outer triazole rings and at 
δ  146.4 and 122.9 ppm for the carbons of the inner triazole rings). In addition, only one 
signal is detected for all the carbonyl groups (δ  163.8 ppm) and the sp3 carbons of the C60 (δ 
 69.3 ppm), while the malonate bridgehead carbons present in the structure are observed at 
δ  45.2 ppm. 
Additional characterization was achieved by DLS analysis (H2O, 0.01 mg/mL and 0.1 mg/mL), 
where, regardless the concentration used, we found two or three main size distributions for 
17a-c (Supplementary Figure 1). This is compatible with a weak aggregation of 17a-c in water. 
The first, around 5-6 nm, must correspond to only one molecule, while the second, at 120-
150 nm and third, 200 nm, show the aggregation of several molecules. In DMSO (0.1 mg/mL) 
(Supplementary Figure 2), although most of the molecules show no aggregation, the presence 
of aggregates of different sizes and, especially, very large aggregates, is also detected. The 
tendency to form aggregates was also confirmed by the broadening of the 13C NMR spectrum 
recorded in D2O when compared to the one recorded in DMSO-d6 (see Supplementary 
Information). 
The TEM images of freshly prepared samples reveal the presence of small spherical particles, 
corresponding to a few or even just one molecule (4 nm), independently of whether the 
concentration is 0.01 mg/mL or 0.1 mg/mL, in good agreement with the experimental findings 
in DLS analyses (Figure 5 and Supplementary Figure 3). 
X-ray photoelectron spectroscopy (XPS) was additionally used to confirm the composition of 
the sugar balls. This surface technique enables the identification of the atoms present on the 
molecule together with their chemical state and their relative abundance. The survey spectra 
of superball 17a (Supplementary Figure 4) displays the C 1s, O 1s and N 1s features as 
expected, with no additional spectroscopy signatures of possible impurities. Moreover, the 
high resolution N 1s core level spectrum (Supplementary Figure 4, inset right) was composed 
of two different components with a 1:2 ratio of the integrated areas, the one located at 400.3 
eV is related to one nitrogen atom of the triazole ring (N–N–N) and the other centered at 
398.8 eV is attributed to the other two nitrogen atoms attached to carbon atoms (C–N).26 The 
absence of a well-resolved peak around 405.0 eV demonstrates the lack of the electron-
deficient nitrogen of the azide group in the final compound.27,28 The composition of 
compounds 17b and 17c has also been ascertained by their respective XPS analyses which 
showed the presence of the expected elements, according to their relative abundance (see 
Supplementary Figure 4 and Supplementary Table 1). 
 
Biological studies 
 
A number of molecules, including DC-SIGN, have been proposed as receptors for the Ebola 
virus 29-31. Although DC-SIGN is not the main receptor in case of Ebola virus, it is thought to play 
a significant role in the cell entrance of this infectious agent in significant cell populations such 
as dendritic cells,29,32 thus facilitating early viral dissemination. Therefore, DC-SIGN can 
function as a good model for (i) studying the first steps of pathogenesis of Ebola virus and (ii) 
screening the antiviral strategies based on DC-SIGN-targeting compounds for prevention and 
treatment purposes. DC-SIGN recognizes mannosylated and fucosylated oligosaccharides 
presented in a multivalent manner on the surface of several pathogen envelope glycoproteins. 
Thus the preparation of multivalent carbohydrate systems is necessary for the efficient 
interaction with this receptor as well as for the effective competition with the natural ligands. 
In this study we have evaluated the inhibitory effect of giant globular multivalent 
glycofullerenes in the experiment of direct infection of Jurkat cells expressing the surface 
receptor DC-SIGN (Jurkat-DC-SIGN with pseudotyped viral particles presenting Ebola virus 
glycoprotein GP1. These globular multivalent systems are water soluble and show no 
cytotoxicity in cell lines allowing the study of their potential biological function in preventing 
viral infection. All multivalent compounds were checked for the possibility of blocking DC-SIGN 
receptor in 6 independent experiments. The results of blocking DC-SIGN receptor by different 
compounds were shown as a function of concentration. The 50% of inhibition of the infection 
was calculated with the 95% confidence interval (CI). As a control, infection with DC-SIGN-
independent VSV glycoprotein-pseudotyped lentiviral particles29 was performed in the same 
conditions. 
 
The results obtained in the infection experiment revealed the dependence of the inhibition 
effect on mannoses. Compound 17b displaying 120 galactoses, as expected, was not able to 
inhibit the infection process mediated by DC-SIGN. Compounds with 120 mannose-based 
residues (17a and 17c) showed very strong antiviral activity at picomolar to nanomolar 
concentrations. Compound 17a could effectively block Ebola virus infection at low nanomolar 
concentrations with an IC50 of 20.37 nM (95%CI = 14.63 – 28.37 nM). Compound 17c was 
almost one order of magnitude more potent at inhibiting the infection process with an IC50 of 
667 pM (95%CI = 411 pM – 1.08 nM) (Figure 6).  
 
Previous inhibition studies using the same infection model and fullerenes displaying up to 36 
mannoses show relative inhibitor potency (RIP) values at least two orders of magnitude 
smaller.19 Moreover, huge virus-like particles (VLP) with a radius of 16 nm and up to 1640 
mannoses32 were 18-fold less potent than compound 17c described in this work (see Table 1). 
These results have confirmed the efficiency of these systems to interact with DC-SIGN and to 
compete with Ebola virus glycoprotein-pseudotyped particles during their entry into target 
cells. 
 
The cytotoxic effect of multivalent glycofullerenes was verified by a cell proliferation assay 
using the Cell Titer 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega). Notably, 
there was not any appreciable cytotoxic effect of compounds 17a-c at the concentration used 
in the infection experiments (see supplementary Figure 6). 
 
Conclusions 
 
In summary, we have synthesized giant globular multivalent glycofullerenes in which the 
central C60 core is covalently connected to twelve hexakis-adducts of C60, thus forming the first 
tridecafullerenes reported so far. Each peripheral fullerene is endowed with ten 
monosaccharides and so a total of 120 carbohydrates decorate the periphery of each 
molecule. This represents the fastest dendrimer growth ever reported, affording molecular 
weights as high as 56 KDa. 
 
The synthesis of non-symmetric hexakis-adducts (7, 9, 14a,b, 15a,b) as well as the 
tridecafullerenes (17a-c) have been accomplished efficiently by using CuAAC click-chemistry 
reactions. In this way, very sophisticated molecular ensembles have been produced in a 
minimum of synthetic steps and their apparent structural complexity is not a limitation for 
their applications. Despite the high molecular weights, the new molecules have been 
characterized by standard spectroscopic techniques (FTIR, 1H NMR, 13C NMR) as well as by DLS, 
XPS and TEM. Interestingly, NMR spectroscopy unambiguously reveals the high degree of 
symmetry (Th) in hexakis-adducts. 
 
Tridecafullerenes are soluble in water and, therefore, they have been tested as globular 
multivalent systems to inhibit lectin-mediated viral infection processes in cellular assays. In 
particular, compounds 17a-c have been used to test their ability to inhibit the infection of cells 
by an artificial Ebola virus. These tridecafullerenes have been found to efficiently block Ebola 
virus infection in the range of sub-nanomolar concentrations. These values surpass by three 
orders of magnitude (two if the number of mannoses is considered) those exhibited by 
hexakis-adducts endowed with 12 mannoses.  
 
The aforementioned results reveal fullerenes to be appealing platforms for the study of 
multivalent interactions particularly because of their biocompatibility and globular 
presentation. Furthermore, the compounds reported here pave the way to the introduction of 
dendritic dimers and trimers of monosaccharides as well as the use of disaccharides to 
significantly improve the scope of the biological applications of tridecafullerenes. 
 
METHODS 
Production of recombinant viruses 
Recombinant viruses were produced in 293T cells. The viral construction was pseudotyped 
with Zaire Ebola virus (ZEBOV) envelope glycoprotein (GP) or vesicular stomatitis virus 
envelope GP (VSV-G) and expressed luciferase as a reporter of the infection.29,33 One day (18-
24 h) before transfection, 5 x 106 293T were seeded onto 10 cm plates. Cells were cultured in 
DMEM medium supplemented with 10% heat-inactivated FBS, 25 mg Gentamycin, 2 mM L-
glutamine. Few minutes before transfection, the medium on transfection plates was changed 
to 9 ml DMEM and chloroquine was added to 25µM final concentration. Transfection reaction 
with all reagents at room temperature (RT) was prepared in 15 ml tubes: 183 µl of 2M CaCl2, 
500 ng of EBOV-GP or 2 µg of VSV-G, 21 µg of pNL4-3 luc34, 1300 µl of H2O. Next, 1.5 ml of 
2xHBS (Hepes Buffer Saline) pH 7.00 was added quickly to the tubes and bubbled for 30 
seconds. HBS/DNA solution was gently dropped onto medium. After 8 hours of incubation at 
37º C with 5% CO2, medium on transfection plates was changed to 10 ml DMEM and once 
again one day after transfection to 7 ml DMEM. Transfection supernatants were harvested 
after 48 h, centrifuged at 1200 rpm for 10 minutes at RT to remove cell debris, and stored 
frozen at -80° C.32,33,35 
Ebola virus infection experiments  
Infection was performed on Jurkat cells (T-lymphocyte cell line) expressing receptor DC-SIGN 
on its surface. Since Ebola virus does not infect T-lymphocytes, its entry is absolutely 
dependent on DC-SIGN for infection of Jurkat cells.29,36 
Jurkat-DC-SIGN cells (2.5 x 105) were plated into each well of 96-well plate. Cells were 
incubated at RT for 20 minutes with the carbohydrate-based compounds and then challenged 
with 5000 TCID (Tissue Culture Infective Dose) of recombinant viruses. After 48 h of incubation 
cells were washed twice with PBS and assayed with the Luficerase Assay System (Promega, 
Madison, WI). 
The range of concentrations tested for compounds 17a-c was 1 pM – 10 µM. As a control, 
experiment of infection with VSV-G pseudoviruses was performed in the same conditions. 
Infection with VSV-G is independent of the presence of DC-SIGN receptor. 
Statistical analysis 
The values of percentage of inhibition of the infection presented on the graph correspond to 
the mean of 6 independent experiments with error bars corresponding to the standard errors 
of the mean. The IC50s values were estimated using GraphPad Prism v6.0 with a 95% 
confidence interval and settings for normalize dose-response curves. 
Cytotoxicity assay 
The Cell Titer 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega) was used. 
Jurkat-DC-SIGN (5 x 105 cells/well) were seeded into wells of 96-well plate and left cultured in 
the presence of different concentrations of glycofullerenes for the time of infection assay. 
After 48 h, the proliferation cell assay was performed. Briefly, the 2 ml MTS solution was mixed 
with 100 µl of PMS solution. The mix MTS/PMS in a volume of 20 µl was pipetted into each 
well of the 96-well assay plate containing 100 µl of cells in culture medium. The plate was 
incubated for 2 h at 37º C in a humidified 5% CO2 atmosphere. After incubation time, the 
absorbance at 490 nm was recorded using an ELISA plate reader. As a control of toxicity, the 
viability of cells in the presence of 0.1% Triton-X100 was measured. The results of the assay 
were presented as the percentage of cells viability, which was calculated from the absorbance 
at 490 nm as compared to absorbance shown by cells incubated without addition of 
glycofullerenes representing 100 % of cells viability. 
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Figure Captions 
 
Figure 1. Synthesis of azide substituted glycofullerene 9 appended with a long linker and 
mannose as the carbohydrate unit. The figure describes the 5 linear steps required to prepare 
compound 9 in a 26% overall yield. Reagents and conditions: (i) ethylmalonyl chloride, 
pyridine, CH2Cl2, 0 to 25°C, 1 h (99%); (ii) C60, I2, 1,8-Diazabicycloundec-7-ene (DBU), 25 °C, 
PhMe, 16 h (49%); (iii) CBr4, DBU, 25 °C, o-dichorobenzene (ODCB), 72 h (67%); (iv) 
CuSO4.5H2O, sodium ascorbate, THF/H2O, 100°C (MW), 2 h (91%); (v) 8 (19 equiv.), 
CuSO4.5H2O, sodium ascorbate, Tetrabutylammonium fluoride (TBAF), Tetrahydrofurane/H2O, 
80°C (Microwave), 1.5 h (87%). 
 
Figure 2. Synthetic pathway to azide substituted glycofullerenes 15a-b with a short spacer. 
Mannose and galactose are employed as carbohydrates. The peripheral glycofullerene units 
15a-b have been prepared as described in the figure using the Bingel conditions and the 
CuAAC click chemistry to conjugate the carbohydrate moieties. Reagents and conditions: (i) 
di(pent-4-yn-1-yl) malonate, CBr4, DBU, 20 °C, Tol, 72 h (49%); (ii) 2-azidoethyl α-D-
mannopyranoside for 14a (or 2-azidoethyl α-D-galactopyranoside for 14b), CuBr·S(CH3)2, 
sodium ascorbate, Cu0, dimethylsulfoxide (DMSO), 72 h (14a: 86%; 14b: 86%); (iii) NaN3, 70 °C 
(MW), DMSO, 3 h (15a: 84%; 15b: 81%). 
 
Figure 3. Synthesiss of the tridecafullerenes 17a-c using the copper-catalyzed azide–alkyne 
cycloaddition (CuAAC) click-chemistry methodology. The figure describes the conjugation of 
the core fullerene 16 endowed with 12 alkyne groups and the peripheral fullerenes 9 and 15a-
b by click chemistry. Reagents and conditions: For compounds 17a-b: (i) 15a-b, CuBr·S(CH3)2, 
sodium ascorbate, Cu0, DMSO, 25°C, 48 h [17a (from 15a): 73%; 17b (from 15b): 79%]. For 
compound 17c: (i) 9, CuSO4.5H2O, sodium ascorbate, THF/H2O, 80°C (MW), 2 h (76%). 
 
Figure 4. 13C NMR spectrum of tridecafullerene 17a in DMSO-d6. Assignment of the most 
representative signals is depicted. This spectrum is in full agreement with its T-symmetrical 
structure and allows to confirm the complete functionalization of the alkyne moieties in 
precursor 16, as the signals corresponding to the sp carbons are not present anymore. 
 Figure 5. TEM images of tridecafullerene 17a. These images show small spherical particles 
with a diameter of around 4 nm corresponding to a single molecule. a) TEM images of 
compound 17a upon deposition of a 0.01 mg/mL solution in H2O. b) Detail of a particle 
corresponding apparently to one molecule. c) Width profile of the particle shown in b) which 
has a diameter of  4 nm in accordance with the DLS data. 
 
Figure 6. Biological study of tridecafullerenes (17a-c). The graphic shows the inhibition of 
infection with EBOV or VSV GP-pseudotyped lentiviral particles of Jurkat DC-SIGN+ cells using 
17a (blue), 17b (green) and 17c (red). In the cis-infection experiments 2.5x105Jurkat DC-SIGN+ 
were challenged with 5000 Tissue Culture Infective Dose (TCID) of recombinant lentiviral 
particles. Results represent the mean of 6 independent experiments +/- SEM. Compounds 17a 
and 17c show a strong inhibitory activity when EBOV GP pseudotyped lentiviral particles are 
used. No inhibitory activity is detected when VSV GP pseudotyped particles (control) are used 
as infective agent. Compound 17b endowed with galactoses as carbohydrate units does not 
show inhibitory activity because is not able to block DC-SIGN receptor. 
 
Table 1. Comparative of IC50 values and relative inhibitory potency of different mannosylated 
multivalent compounds in inhibition studies using pseudotyped Ebola virus particles. The table 
shows the data for the new compounds 17a and 17c described in comparison with those 
carbohydrate multivalent systems previously reported by us. 
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